Kimba
Elevating Health and Sleep Through AI and Scent Technology
Company Overview
Snapshot
Founded in January 2024 by Ben Fuxbruner and Gabi Beck, Kimba operates with 1–10 employees. The company has raised $6.5M across two funding rounds from 7 investors.
Business overview
Kimba develops scent-based personal limbic therapy, leveraging AI to analyze biometric data and deliver personalized scent therapy. This technology aims to improve sleep and overall health. The company operates within the Health Tech & Life Sciences sector, with a focus on Medical Devices, and serves markets related to healthcare, patients, consumers, and recreational & lifestyle segments.
Strategic signal
In June 2026, Kimba emerged from stealth mode, revealing its AI-powered personalized scent therapy system designed to enhance sleep quality and recovery. This development signals the company's readiness to introduce its innovative approach to the market, particularly targeting individuals with sleep issues, including military veterans with PTSD, and highlights its potential to disrupt traditional wellness and health tech sectors with a novel, data-driven solution.
Log in to access full profile ›Company Intelligence Q&A
- When was Kimba founded?
- Kimba was founded in January 2024.
- Who are the founders of Kimba?
- Kimba was co-founded by Ben Fuxbruner, who serves as CEO, and Gabi Beck, who is the CTO.
- What is Kimba's primary focus?
- Kimba focuses on developing AI-powered, scent-based personal limbic therapy to analyze biometric data and provide personalized scent therapy for improving sleep and health.